 Article
|
|
|
|
Services
|
|
|
|
Google Scholar
|
|
|
|
PubMed
|
|
|
|
LETTER
Omeprazole, Serum Gastrin, and Gastric Acid Suppression
R. Matthew Gideon;
Vera Paoletti; and
Donald O. Castell
1 February 1995 | Volume 122 Issue 3 | Pages 237-238
TO THE EDITOR:
It is well known that the decrease in gastric activity caused by omeprazole results in increased serum gastrin levels. We asked whether a precise relation exists between fasting serum gastrin levels and gastric acid suppression in patients receiving omeprazole. If such a relation exists, physicians could obtain fasting serum gastrin levels from their patients receiving omeprazole as a simple measure of the degree of gastric acid suppression. We used ambulatory intragastric pH monitoring to assess gastric acid suppression in 45 patients with gastroesophageal reflux who were receiving different doses of omeprazole. The pH probe was placed with the antimony electrode in the gastric fundus, 10 cm below the manometrically located lower esophageal sphincter. Monitoring was accomplished using a battery-powered Mark 3 Digitrapper (Synetics Medical, Inc., Irving, Texas). Serum gastrin was drawn after an overnight fast, immediately after placement of the pH probe, and at the start of 24-hour monitoring.
Figure 1 shows the relation between the total percentage of the time intragastric pH remained less than 4.0 over the entire 24-hour period and fasting serum gastrin levels, obtained on the testing day and expressed in pg/mL for patients receiving daily omeprazole doses of 20, 40, and 80 mg. Regression analysis shows a poor correlation (r = 0.04) when the collective fasting serum gastrin levels are compared with the total percentage of time the intragastric pH remained less than 4.0 in the 45 patients receiving omeprazole therapy. Many patients receiving various omeprazole doses had fasting gastrin values in the normal range (<100 pg/mL).
To determine whether this relation was affected by the omeprazole dose, we also compared the fasting serum gastrin level with the total percentage of time the intragastric pH remained less than 4.0 on individual doses. A poor correlation was consistently found at all dose levels.
We conclude that serum gastrin levels do not reliably predict the degree of gastric acid suppression in patients receiving omeprazole.
|
Author and Article Information
|
|---|
 Top
 Author & Article Info
|
|---|
The Graduate Hospital, Philadelphia, PA 19146.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
|
Article
|
|
|
|
Services
|
|
|
|
Google Scholar
|
|
|
|
PubMed
|
|
|
|
= 20 mg; 
= 40 mg; 
= 80 mg.